Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle

Diabetologia

Volumn 59, Issue 1, 2016, Pages 176-186

  Ciccarelli, Marco ^a,b   Vastolo, Viviana ^a,b   Albano, Luigi ^a,b   Lecce, Manuela ^a,b   Cabaro, Serena ^a,b   Liotti, Antonietta ^a,b   Longo, Michele ^a,b   Oriente, Francesco ^a,b   Russo, Gian Luigi ^b   Macchia, Paolo Emidio ^a   Formisano, Pietro ^a,b   Beguinot, Francesco ^a,b   Ungaro, Paola ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Chromatin remodelling; GLUT4; Histone modification enzymes; NF B; Prep1; Type 2 diabetes

Indexed keywords

ACYLTRANSFERASE; GLUCOSE; GLUCOSE TRANSPORTER 4; HISTONE; HISTONE DEACETYLASE 5; HISTONE H3; HISTONE METHYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOCYTE ENHANCER FACTOR 2; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PREP1; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; HOMEODOMAIN PROTEIN; PKNOX1 PROTEIN, MOUSE;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; HISTONE MODIFICATION; LIGHT CHAIN; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GLUCOSE BLOOD LEVEL; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PROCESSING;

ANIMALS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, TYPE 2; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GLUCOSE; HISTONES; HOMEODOMAIN PROTEINS; INFLAMMATION; INSULIN RESISTANCE; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NF-KAPPA B; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84949324174     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3774-6     Document Type: Article

References (52)

1. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074–1080
2. Pennisi E (2001) Behind the scenes of gene expression. Science 293:1064–1067
3. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068–1070
4. Feige JN, Auwerx J (2007) Transcriptional coregulators in the control of energy homeostasis trends. Cell Biol 17:292–301
5. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32–42
6. Rosenfeld MG, Lunyak VV, Grass CK (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405–1428
7. Smith CL, O'Malley BW (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45–71
8. Spiegelman BM, Heinrich R (2004) Biological control through regulated transcriptional coactivators. Cell 119:157–167
9. Kelly TK, De Carvalho DD, Jones PA (2010) Epigenetic modifications at therapeutic targets. Nat Biotechnol 28:1069–1078
10. Encode Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57–74
11. American Association for Cancer Research Epigenome Task Force, European Union Network of Excellence Scientific Advisory Board (2008) Moving AHEAD with an international human epigenome project. Nature 454:711–715
12. Kirchner H, Osler ME, Krook A, Zierath JR (2013) Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol 23:203–209
13. Vileneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R (2008) Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. PNAS 105:9047–9052
14. Schwentk RW, Vogel H, Schurmann A (2013) Genetic and epigenetic control of metabolic health. Mol Metab 2:337–347
15. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
16. Cooper ME, El-Osta A (2010) Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107:1403–1413
17. Reddy MA, Natarajan R (2011) Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 90:421–429
18. Villeneuve LM, Natarajan R (2010) The role of epigenetics in the pathology of diabetic complications. Am J Physiol Ren Physiol 299:F14–F25
19. Pirola L, Balcerczyk A, Okabe J, El-Osta A (2010) Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 6:665–675
20. King GL, Brownlee M (2005) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin N Am 25:225–270
21. Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia–induced oxidant stress-dependent and -independent pathways. J Biol Chem 275:17728–17739
22. Shanmugam N, Reddy M, Guha M, Natarajan R (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52:1256–1264
23. Li Y, Reddy M, Miao F et al (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kB-dependent inflammatory genes. J Biol Chem 283:26771–26781
24. Ungaro P, Teperino R, Mirra P et al (2010) Hepatocyte nuclear factor (HNF)–4alpha–driven epigenetic silencing of the human PED gene. Diabetologia 53:1482–1492
25. Caruso M, Miele C, Oriente F et al (1999) In L6 skeletal muscle cells, glucose induces cytosolic translocation of protein kinase C-alpha and transactivates the insulin receptor kinase. J Biol Chem 274:28637–28644
26. Ungaro P, Mirra P, Oriente F et al (2012) Peroxisome proliferator–activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1. J Biol Chem 287:42951–42961
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real time quantitative PCR and the 2(−ΔΔC(T)) method. Methods 25:402–408
28. Whelan JA, Russell NB, Whelan MA (2003) A method for the absolute quantification of cDNA using real time PCR. J Immunol Methods 278:261–269
29. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489
30. Ungaro P, Teperino R, Mirra P et al (2008) Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4α and chicken ovalbumin upstream promoter transcription factor II. J Biol Chem 283:30970–30979
31. Ferretti E, Villaescusa JC, Di Rosa P et al (2006) Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol 26:5650–5662
32. Baker RG, Hayden MS, Ghosh S (2011) NF-kB, inflammation, and metabolic disease. Cell Metab 13:11–22
33. Sheppard KA, Rose DW, Haque ZK et al (1999) Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19:6367–6378
34. Zhong H, May MJ, Jimi E, Ghosh S (2002) The phosphorylation status of nuclear NF-kappa b determines its association with CBP/p300 or HDAC–1. Mol Cell 9:625–636
35. Oriente F, Iovino S, Cabaro S et al (2011) Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 60:138–147
36. Oriente F, Fernandez Diaz LC, Miele C et al (2008) Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol 28:5634–5645
37. McGee SL, van Denderen BJW, Howlett KF et al (2008) AMP–activated protein kinase regulates glut4 transcription by phosphorylating histone deacetylase 5. Diabetes 57:860–867
38. Petronis A (2010) Epigenetics as a unifying principle in the aetiology of complex traits and disease. Nature 465:721–727
39. Vincent AM, Calabek B, Roberts L, Feldman EL (2013) Biology of diabetic neuropathy. Handb Clin Neurol 115:591–606
40. Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137–188
41. Miao F, Gonzalo G, Lanting L, Natarajan R (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279:18091–18097
42. Hofmann MA, Schiekofer S, Kanitz M et al (1998) Insufficient glycemic control increases nuclear factor–κB binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21:1310–1316
43. Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319–1331
44. Ramasamy R, Yan SF, Schmidt AM (2011) receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243:88–102
45. Neufer PD, Carey JO, Dohm GL (1993) Transcriptional regulation of the gene for glucose transporter GLUT4 in skeletal muscle: effects of diabetes and fasting. J Biol Chem 268:13824–13829
46. Thai MV, Guruswamy S, Cao KT, Pessin JE, Olson AL (1998) Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice: regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 273:14285–14292
47. McKinsey TA, Zhang CL, Olson EN (2001) Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev 11:497–504
48. McGee SL, Hargreaves M (2004) Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 53:1208–1214
49. Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Pedersen O (1993) Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77:27–32
50. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J (1996) Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45:23–27
51. Ren JM, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM, Shulman GI (1995) Overexpression of Glut4 protein in muscle increases basal and insulin–stimulated whole body glucose disposal in conscious mice. J Clin Invest 95:429–432
52. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ (1996) Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45:28–36